1. Schachat AP, Wilkinson CP, Hinton DR, et al. Ryan's Retina. 6th ed. Vol. 2. St. Louis: Elsevier;2017. p. 1038.
2. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984; 102:527–532.
3. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991; 98:5 Suppl. 823–833.
4. Knol JA, van Kooij B, de Valk HW, Rothova A. Rapid progression of diabetic retinopathy in eyes with posterior uveitis. Am J Ophthalmol. 2006; 141:409–412.
5. Dev S, Pulido JS, Tessler HH, et al. Progression of diabetic retinopathy after endophthalmitis. Ophthalmology. 1999; 106:774–781.
6. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998; 116:874–886.
7. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed). 1985; 290:811–815.
8. Tsai FY, Lau LI, Li AF, et al. Acute macular edema and peripapillary soft exudate after pancreas transplantation with accelerated progression of diabetic retinopathy. J Chin Med Assoc. 2017; 80:319–325.
9. Grunwald JE, Riva CE, Martin DB, et al. Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. Ophthalmology. 1987; 94:1614–1620.
10. Koo NK, Kim YC. Resolution of macular edema after systemic treatment with furosemide. Korean J Ophthalmol. 2012; 26:312–315.
11. Bhalla V, Isakson S, Bhalla MA, et al. Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients. Am J Hypertens. 2005; 18(2 Pt 2):73S–81S.